Skip to main content

Research Repository

Advanced Search

A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C

Napolitano, Federico; Merone, Rossella; Abbate, Adele; Ammendola, Virginia; Horncastle, Emma; Lanzaro, Francesca; Esposito, Marialuisa; Contino, Alessandra Maria; Sbrocchi, Roberta; Sommella, Andrea; Duncan, Joshua D.; Hinds, Jospeh; Urbanowicz, Richard A.; Lahm, Armin; Colloca, Stefano; Folgori, Antonella; Ball, Jonathan K.; Nicosia, Alfredo; Wizel, Benjamin; Capone, Stefania; Vitelli, Alessandra

Authors

Federico Napolitano

Rossella Merone

Adele Abbate

Virginia Ammendola

Emma Horncastle

Francesca Lanzaro

Marialuisa Esposito

Alessandra Maria Contino

Roberta Sbrocchi

Andrea Sommella

Joshua D. Duncan

Jospeh Hinds

Armin Lahm

Stefano Colloca

Antonella Folgori

JONATHAN BALL jonathan.ball@nottingham.ac.uk
Professor of Molecular Virology

Alfredo Nicosia

Benjamin Wizel

Stefania Capone

Alessandra Vitelli



Abstract

Rabies, caused by RNA viruses in the Genus Lyssavirus, is the most fatal of all infectious diseases. This neglected zoonosis remains a major public health problem in developing countries, causing the death of an estimated 25,000-159,000 people each year, with more than half of them in children. The high incidence of human rabies in spite of effective vaccines is mainly linked to the lack of compliance with the complicated administration schedule, inadequacies of the community public health system for local administration by the parenteral route and the overall costs of the vaccine. The goal of our work was the development of a simple, affordable and effective vaccine strategy to prevent human rabies virus infection. This next generation vaccine is based on a replication-defective chimpanzee adenovirus vector belonging to group C, ChAd155-RG, which encodes the rabies glycoprotein (G). We demonstrate here that a single dose of this vaccine induces protective efficacy in a murine model of rabies challenge and elicits strong and durable neutralizing antibody responses in vaccinated non-human primates. Importantly, we demonstrate that one dose of a commercial rabies vaccine effectively boosts the neutralizing antibody responses induced by ChAd155-RG in vaccinated monkeys, showing the compatibility of the novel vectored vaccine with the current post-exposure prophylaxis in the event of rabies virus exposure. Finally, we demonstrate that antibodies induced by ChAd155-RG can also neutralize European bat lyssaviruses 1 and 2 (EBLV-1 and EBLV-2) found in bat reservoirs.

Citation

Napolitano, F., Merone, R., Abbate, A., Ammendola, V., Horncastle, E., Lanzaro, F., …Vitelli, A. (2020). A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C. PLoS Neglected Tropical Diseases, 14(7), https://doi.org/10.1371/journal.pntd.0008459

Journal Article Type Article
Acceptance Date Jun 5, 2020
Online Publication Date Jul 15, 2020
Publication Date Jul 1, 2020
Deposit Date Jul 17, 2020
Publicly Available Date Jul 20, 2020
Journal PLoS neglected tropical diseases
Electronic ISSN 1935-2735
Publisher Public Library of Science
Peer Reviewed Peer Reviewed
Volume 14
Issue 7
Article Number e0008459
DOI https://doi.org/10.1371/journal.pntd.0008459
Keywords Public Health, Environmental and Occupational Health; Infectious Diseases
Public URL https://nottingham-repository.worktribe.com/output/4772568
Publisher URL https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008459

Files

next generation vaccine against human rabies (2.2 Mb)
PDF

Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/





You might also like



Downloadable Citations